S&P 500   4,263.75 (+0.81%)
DOW   33,129.55 (+0.39%)
QQQ   359.75 (+1.36%)
AAPL   173.66 (+0.73%)
MSFT   318.96 (+1.77%)
META   305.58 (+1.54%)
GOOGL   135.24 (+2.12%)
AMZN   127.00 (+1.83%)
TSLA   261.16 (+5.93%)
NVDA   440.41 (+1.20%)
NIO   8.83 (+2.56%)
BABA   84.05 (-0.58%)
AMD   104.07 (+3.99%)
T   14.65 (-0.88%)
F   11.98 (-0.75%)
MU   68.11 (+0.41%)
CGC   0.75 (+10.25%)
GE   108.85 (+1.01%)
DIS   79.30 (-0.30%)
AMC   8.34 (+6.24%)
PFE   33.29 (-1.80%)
PYPL   58.57 (+2.22%)
NFLX   376.90 (+0.04%)
S&P 500   4,263.75 (+0.81%)
DOW   33,129.55 (+0.39%)
QQQ   359.75 (+1.36%)
AAPL   173.66 (+0.73%)
MSFT   318.96 (+1.77%)
META   305.58 (+1.54%)
GOOGL   135.24 (+2.12%)
AMZN   127.00 (+1.83%)
TSLA   261.16 (+5.93%)
NVDA   440.41 (+1.20%)
NIO   8.83 (+2.56%)
BABA   84.05 (-0.58%)
AMD   104.07 (+3.99%)
T   14.65 (-0.88%)
F   11.98 (-0.75%)
MU   68.11 (+0.41%)
CGC   0.75 (+10.25%)
GE   108.85 (+1.01%)
DIS   79.30 (-0.30%)
AMC   8.34 (+6.24%)
PFE   33.29 (-1.80%)
PYPL   58.57 (+2.22%)
NFLX   376.90 (+0.04%)
S&P 500   4,263.75 (+0.81%)
DOW   33,129.55 (+0.39%)
QQQ   359.75 (+1.36%)
AAPL   173.66 (+0.73%)
MSFT   318.96 (+1.77%)
META   305.58 (+1.54%)
GOOGL   135.24 (+2.12%)
AMZN   127.00 (+1.83%)
TSLA   261.16 (+5.93%)
NVDA   440.41 (+1.20%)
NIO   8.83 (+2.56%)
BABA   84.05 (-0.58%)
AMD   104.07 (+3.99%)
T   14.65 (-0.88%)
F   11.98 (-0.75%)
MU   68.11 (+0.41%)
CGC   0.75 (+10.25%)
GE   108.85 (+1.01%)
DIS   79.30 (-0.30%)
AMC   8.34 (+6.24%)
PFE   33.29 (-1.80%)
PYPL   58.57 (+2.22%)
NFLX   376.90 (+0.04%)
S&P 500   4,263.75 (+0.81%)
DOW   33,129.55 (+0.39%)
QQQ   359.75 (+1.36%)
AAPL   173.66 (+0.73%)
MSFT   318.96 (+1.77%)
META   305.58 (+1.54%)
GOOGL   135.24 (+2.12%)
AMZN   127.00 (+1.83%)
TSLA   261.16 (+5.93%)
NVDA   440.41 (+1.20%)
NIO   8.83 (+2.56%)
BABA   84.05 (-0.58%)
AMD   104.07 (+3.99%)
T   14.65 (-0.88%)
F   11.98 (-0.75%)
MU   68.11 (+0.41%)
CGC   0.75 (+10.25%)
GE   108.85 (+1.01%)
DIS   79.30 (-0.30%)
AMC   8.34 (+6.24%)
PFE   33.29 (-1.80%)
PYPL   58.57 (+2.22%)
NFLX   376.90 (+0.04%)
NASDAQ:BIOL

BIOLASE (BIOL) News Today

$1.83
+0.01 (+0.55%)
(As of 10/4/2023 ET)
Compare
Today's Range
$1.75
$1.88
50-Day Range
$1.59
$675.00
52-Week Range
$1.56
$255.00
Volume
74,309 shs
Average Volume
133,820 shs
Market Capitalization
$1.90 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$513.50
SourceHeadline
finance.yahoo.com logoBIOLASE Inc. Announces Closing of $4.5 Million Underwritten Public Offering of Series J Convertible Redeemable Preferred Stock and Warrants
finance.yahoo.com - September 18 at 5:11 PM
benzinga.com logoHere's Why BIOLASE Shares Were Volatile This Week
benzinga.com - September 15 at 1:20 PM
benzinga.com logoWhy BIOLASE Stock Is Getting Obliterated Thursday
benzinga.com - September 14 at 2:55 PM
msn.com logoBIOLASE down 30%, prices $4.5M stock offering
msn.com - September 14 at 9:54 AM
marketwatch.com logoBiolase Shares Plummet After Offering Prices
marketwatch.com - September 14 at 9:54 AM
finance.yahoo.com logoBIOLASE Inc. Announces Pricing of $4.5 Million Underwritten Public Offering of Series J Convertible Redeemable Preferred Stock and Warrants
finance.yahoo.com - September 13 at 11:57 PM
finanznachrichten.de logoBIOLASE, Inc.: Biolase Reports Record Consumable Sales As Total Second Quarter Revenue Increases 17% Year Over Year
finanznachrichten.de - August 11 at 7:38 PM
finance.yahoo.com logoQ2 2023 BIOLASE Inc Earnings Call
finance.yahoo.com - August 11 at 7:38 PM
msn.com logoBiolase Non-GAAP EPS of -$4.24 beats by $1.76, revenue of $14.3M misses by $1.06M
msn.com - August 11 at 3:14 AM
sfgate.com logoBiolase: Q2 Earnings Snapshot
sfgate.com - August 11 at 3:14 AM
finance.yahoo.com logoBIOLASE REPORTS RECORD CONSUMABLE SALES AS TOTAL SECOND QUARTER REVENUE INCREASES 17% YEAR OVER YEAR
finance.yahoo.com - August 11 at 3:14 AM
finance.yahoo.com logoBIOLASE, Inc. (BIOL) Interactive Stock Chart - Yahoo Finance
finance.yahoo.com - August 10 at 10:23 AM
markets.businessinsider.com logoHere's what Wall Street expects from Biolase's earnings report
markets.businessinsider.com - August 9 at 6:20 PM
marketbeat.com logo
marketbeat.com - August 8 at 3:41 PM
finance.yahoo.com logoBIOLASE TO REPORT SECOND QUARTER 2023 RESULTS ON AUGUST 10, 2023
finance.yahoo.com - August 3 at 8:48 AM
finanznachrichten.de logoBIOLASE, Inc.: Biolase Announces 1-for-100 Reverse Stock Split
finanznachrichten.de - July 28 at 10:44 AM
finance.yahoo.com logoBIOLASE ANNOUNCES 1-FOR-100 REVERSE STOCK SPLIT
finance.yahoo.com - July 26 at 7:51 PM
fool.com logoBiolase (NASDAQ: BIOL)
fool.com - July 23 at 12:26 AM
finance.yahoo.com logoBIOLASE EPIC HYGIENE DENTAL LASER RECEIVES PRESTIGIOUS CELLERANT BEST OF CLASS HYGIENE AWARD
finance.yahoo.com - July 17 at 8:35 AM
msn.com logoBiolase (BIOL) Price Target Decreased by 6.09% to 2.75
msn.com - July 6 at 10:17 PM
finance.yahoo.com logoMedical Laser Market to Grow Rapidly at a CAGR of ~14.8% by 2030 | DataM Intelligence
finance.yahoo.com - June 29 at 1:20 PM
finance.yahoo.com logoBIOLASE Announces Grand Opening of Training Facility to Reach Wider Universe of Dental Practitioners; First-Hand Experience Using Leading Dental Laser Technology Expected to Generate Increased Revenue Opportunities
finance.yahoo.com - June 15 at 8:14 AM
finance.yahoo.com logoBIOLASE TO PARTICIPATE IN MAXIM GROUP'S 2023 VIRTUAL HEALTHCARE CONFERENCE HOSTED BY M-VEST ON JUNE 20TH - 22ND
finance.yahoo.com - June 14 at 7:40 PM
finance.yahoo.com logoBIOLASE INTEGRATES DIODE LASER TECHNOLOGY WITH PET DENTAL SERVICES
finance.yahoo.com - June 14 at 9:39 AM
markets.businessinsider.com logoMaxim Group Sticks to Their Buy Rating for Biolase (BIOL)
markets.businessinsider.com - June 7 at 8:23 AM
finance.yahoo.com logoBIOLASE ANNOUNCES DISTRIBUTION OF SERIES I PREFERRED STOCK TO HOLDERS OF ITS COMMON STOCK
finance.yahoo.com - June 5 at 9:18 PM
marketwatch.com logoBiolase to Cut 20% of Workforce
marketwatch.com - June 5 at 11:11 AM
msn.com logoBIOLASE to cut 20% of US workforce to achieve sales and profitability goals
msn.com - June 5 at 11:11 AM
nasdaq.com logoLake Street Maintains Biolase (BIOL) Buy Recommendation
nasdaq.com - June 1 at 8:18 AM
finance.yahoo.com logoBIOLASE Inc. Announces Closing of $4.5 Million Underwritten Public Offering of Series H Convertible Redeemable Preferred Stock and Warrants
finance.yahoo.com - May 26 at 3:33 PM
marketwatch.com logoBiolase Hits 52-Week Low of 7 Cents After Offering Prices
marketwatch.com - May 24 at 3:12 PM
benzinga.com logoBiolase shares are trading lower after the company announced the pricing of a $4.5 million underwritten public offering.
benzinga.com - May 24 at 10:11 AM
finance.yahoo.com logoBIOLASE Inc. Announces Pricing of $4.5 Million Underwritten Public Offering of Series H Convertible Redeemable Preferred Stock and Warrants
finance.yahoo.com - May 24 at 10:11 AM
marketwatch.com logoGlobal Electronic Caries Monitors (ECM) Market Size 2023-2031 Technological Innovations by Absolute Reports | with [119 Pages]
marketwatch.com - May 13 at 8:10 AM
finance.yahoo.com logoBIOLASE MAINTAINS MOMENTUM AND REPORTS NINTH CONSECUTIVE QUARTER OF YEAR-OVER-YEAR GROWTH; REITERATES FULL YEAR GUIDANCE OF AT LEAST 25% REVENUE GROWTH AND PROFITABILITY FOR FULL YEAR 2023
finance.yahoo.com - May 11 at 5:10 PM
msn.com logoEarnings Outlook For Biolase
msn.com - May 10 at 1:29 PM
markets.businessinsider.com logoBiolase earnings: here's what Wall Street expects
markets.businessinsider.com - May 10 at 1:29 PM
marketwatch.com logoLaser Medical Instrument Market Size, Business Segments, Innovative Strategies And Outlook by 2030| El.En., Lumenis, BIOLASE
marketwatch.com - May 10 at 12:22 AM
finance.yahoo.com logoBIOLASE TO REPORT FIRST QUARTER 2023 RESULTS ON MAY 11, 2023
finance.yahoo.com - May 4 at 8:30 PM
marketwatch.com logoGlobal Dental Products Market by [2023-2029] with Revenue Outsourcing
marketwatch.com - April 22 at 8:55 AM
marketwatch.com logoDental Hand Instruments Market Facts and Figures By 2030
marketwatch.com - April 9 at 8:06 AM
marketwatch.com logoSemiconductor Laser Therapeutic Equipment Market Demand by 2030
marketwatch.com - April 8 at 10:14 AM
insidermonkey.com logoBIOLASE, Inc. (NASDAQ:BIOL) Q4 2022 Earnings Call Transcript
insidermonkey.com - March 30 at 8:30 AM
finance.yahoo.com logoBIOLASE DELIVERS 24% REVENUE GROWTH IN 2022 AS GO-TO-MARKET STRATEGIES GAIN MOMENTUM; GUIDES FOR AT LEAST 25% REVENUE GROWTH AND PROFITABILITY IN 2023
finance.yahoo.com - March 28 at 8:27 PM
marketwatch.com logoLaser Medical Devices Market Outlook and Forecast to 2030 | BIOLASE, Philips, IRIDEX Corporation
marketwatch.com - March 26 at 10:25 AM
marketwatch.com logoDental Equipment Market Growth and Forecast till 2031
marketwatch.com - March 24 at 9:56 AM
marketwatch.com logoDental X-ray Market Share and Forecast till 2028
marketwatch.com - March 17 at 9:21 AM
finance.yahoo.com logoBIOLASE GATHERS KEY OPINION LEADERS AND DENTAL CLINICIANS TO HIGHLIGHT TONGUE-TIE TREATMENT BEST PRACTICES
finance.yahoo.com - March 14 at 6:56 AM
finance.yahoo.com logoBIOLASE TO REPORT FOURTH QUARTER AND FULL YEAR 2022 RESULTS ON MARCH 28, 2023
finance.yahoo.com - March 13 at 6:58 AM
finance.yahoo.com logoBIOLASE PLANS TO LAUNCH SEASON 2 OF ITS POPULAR PODCAST SERIES
finance.yahoo.com - March 6 at 9:22 AM
Get BIOLASE News Delivered to You Automatically

Sign up to receive the latest news and ratings for BIOL and its competitors with MarketBeat's FREE daily newsletter.



BIOL Media Mentions By Week

BIOL Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

BIOL
News Sentiment

-1.00

0.47

Average
Medical
News Sentiment

BIOL News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

BIOL Articles
This Week

0

1

BIOL Articles
Average Week

Get BIOLASE News Delivered to You Automatically

Sign up to receive the latest news and ratings for BIOL and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:BIOL) was last updated on 10/4/2023 by MarketBeat.com Staff

My Account -